Kazia Therapeutics Limited (NasdaqCM:KZIA) has had its average one-year price target revised to $21.42 per share, a 10.53% increase from the previous estimate of $19.38 dated April 12, 2023. This new target represents an 80.84% increase from its last reported closing price of $11.84 per share.
The number of funds or institutions holding positions in Kazia has increased to 26, marking a 73.33% rise from the last quarter, with total shares owned by institutions skyrocketing by 1,162.60% to 2.48 million shares. The average portfolio weight dedicated to KZIA among all funds is now 0.17%, up 363.85%.
The current put/call ratio for KZIA stands at 0.02, indicating a bullish sentiment in the market.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
